A landscape map of the key global rare disease organizations

References

[1] Chan CH,Pearce DA.The international rare disease research consortium (IRDiRC): making rare disease research efforts more efficient and collaborative around the world.Rare Dis Orphan Drugs J2023;2:28

[2] Mimouni Y,Petton Y.The European joint programme on rare diseases: building the rare diseases research ecosystem.Rare Dis Orphan Drugs J2024;3:17

[3] Brooks PJ,Groft S.The division of rare diseases research innovation at the national center for advancing translational sciences, NIH: mission, history, and current research activities.Rare Dis Orphan Drugs J2024;3:15

[4] Cavaller-Bellaubi M,Favresse R.Framing the European rare diseases field through a structured movement of patient organisations.Rare Dis Orphan Drugs J2024;3:23

[5] Jain R,Foster L,Nishimura Y.Paradox of possibilities: the rare landscape in the Asia Pacific region.Rare Dis Orphan Drugs J2024;3:8

[6] N=1. N1C annual meeting 2024. Available from: https://www.n1collaborative.org [Last accessed on 9 Oct 2024]

[7] Rare Disease Moonshot. Available from: https://www.rarediseasemoonshot.eu/ [Last accessed on 9 Oct 2024]

[8] Rare Diseases International. Available from: https://www.rarediseasesinternational.org/ [Last accessed on 9 Oct 2024]

[9] World Health Organization. Rare diseases. 2013. Available from: https://www.who.int/standards/classifications/frequently-asked-questions/rare-diseases [Last accessed on 9 Oct 2024]

[10] ICORD. 2019. Available from: https://www.icord.es/ [Last accessed on 9 Oct 2024]

[11] Nabbout R,Baker D.Towards the international interoperability of clinical research networks for rare diseases: recommendations from the IRDiRC task force.Orphanet J Rare Dis2023;18:109 PMCID:PMC10169162